GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » Earnings per Share (Diluted)

Simulations Plus (Simulations Plus) Earnings per Share (Diluted) : $0.53 (TTM As of Feb. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Simulations Plus Earnings per Share (Diluted)?

Simulations Plus's Earnings per Share (Diluted) for the three months ended in Feb. 2024 was $0.20. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was $0.53.

Simulations Plus's EPS (Basic) for the three months ended in Feb. 2024 was $0.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2024 was $0.53.

Simulations Plus's EPS without NRI for the three months ended in Feb. 2024 was $0.22. Its EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2024 was $0.60.

During the past 12 months, Simulations Plus's average EPS without NRIGrowth Rate was 15.10% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 9.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 6.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 15.00% per year.

During the past 13 years, Simulations Plus's highest 3-Year average EPS without NRI Growth Rate was 78.70% per year. The lowest was -39.10% per year. And the median was 15.70% per year.


Simulations Plus Earnings per Share (Diluted) Historical Data

The historical data trend for Simulations Plus's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simulations Plus Earnings per Share (Diluted) Chart

Simulations Plus Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.50 0.47 0.60 0.49

Simulations Plus Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.20 0.03 0.10 0.20

Competitive Comparison of Simulations Plus's Earnings per Share (Diluted)

For the Health Information Services subindustry, Simulations Plus's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's PE Ratio distribution charts can be found below:

* The bar in red indicates where Simulations Plus's PE Ratio falls into.



Simulations Plus Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Simulations Plus's Earnings Per Share (Diluted) for the fiscal year that ended in Aug. 2023 is calculated as

Diluted Earnings Per Share (A: Aug. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(9.961-0)/20.465
=0.49

Simulations Plus's Earnings Per Share (Diluted) for the quarter that ended in Feb. 2024 is calculated as

Diluted Earnings Per Share (Q: Feb. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(4.029-0)/20.315
=0.20

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Simulations Plus  (NAS:SLP) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Simulations Plus Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Simulations Plus's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Simulations Plus (Simulations Plus) Business Description

Traded in Other Exchanges
N/A
Address
42505 Tenth Street West, Lancaster, CA, USA, 93534-7059
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
Executives
John Kenneth Paglia director 746 GRABLE PLACE, NEWBURY PARK CA 91320
Walter S Woltosz director, 10 percent owner, officer: Chairman and CEO 42505 10TH ST. WEST, LANCASTER CA 93534
Dibella John Anthony Ii officer: Division President 42505 10TH STREET WEST, LANCASTER CA 93534
Lisa Lavange director 42505 10TH ST., WEST, LANCASTER CA 93534
Steven Chang officer: President, Immunetrics 42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor officer: Chief Executive Officer 42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly officer: President, Cognigen Division 42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell officer: President, DILIsym Division 42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick officer: CFO C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Daniel L Weiner director 800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
Sharlene Evans director 42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen officer: VP of Human Resources 42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph director 42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel officer: CFO 42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr director, officer: President 1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221